Molecular vehicles for therapeutic delivery of lactate in exercise and medicine
Sports Medicine and Health Science · 2026-05 · 8 (3) · 240-246
DOI: 10.1016/j.smhs.2026.03.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Sports Medicine and Health Science, 2026-05. Verfasst von George A Brooks. Beteiligte Einrichtung: Exercise Physiology Laboratory, Department of Integrative Biology, 5101 VLSB, University of California, Berkeley, CA, 94720-3140, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centre for Research on Energy and Clean Air, National Institutes of Health.
Abstract (Originalsprache)
Once thought of as a dead-end metabolite, the product of anaerobic, oxygen-limited metabolism, we now know that lactate is produced under fully oxygenated conditions, such as after consuming dietary carbohydrate and during physical exercise. Via shuttling mechanisms lactate is a preferred fuel energy source for red skeletal muscle, heart and brain. Consequently, lactate is being recognized as a major means of delivering non-insulin dependent carbohydrate-derived carbon around the body. Such recognition has led to consideration of developing enteral and parenteral means of lactate delivery. Enteral lactate delivery can be accomplished by providing fermented foods or high-glycemic index carbohydrates. Parenteral, intravenous (iv) lactate delivery can be accomplished by use of inorganic salts, such as sodium-L-lactate and other electrolyte mixtures appropriate for iv delivery. Enteral lactate delivery has been accomplished by using organic carriers that bind by electrostatic charge to zwitter ion amino acids. As well, it's possible to deliver lactate covalently bound to amino acids such as phenylalanine or glycerol. Some lactate-containing compounds such as LACTEM, sodium- and arginyl-lactate are Generally Recognized As Safe (GRAS) by the FDA for use in food, but other lactate-containing compounds are of unknown bioavailability and will need to pass FDA scrutiny. Enteral use of arginyl-lactate has been shown to be effective for improving performance of endurance athletes, and iv sodium-L-lactate for treatment of traumatic brain injury has reached Stage 2 clinical trials. Scientific background and possibilities of using lactate-containing compounds to achieve better outcomes by athletes or in illnesses and injuries is discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Exercise Physiology Laboratory, Department of Integrative Biology, 5101 VLSB, University of California, Berkeley, CA, 94720-3140, USA.
Förderung
- Centre for Research on Energy and Clean Air
- National Institutes of Health
Zitieren
APA
Brooks, G. A. (2026). Molecular vehicles for therapeutic delivery of lactate in exercise and medicine. Sports Medicine and Health Science, 8(3), 240-246. https://doi.org/10.1016/j.smhs.2026.03.005
Vancouver
Brooks GA. Molecular vehicles for therapeutic delivery of lactate in exercise and medicine. Sports Medicine and Health Science. 2026;8(3):240-246. doi:10.1016/j.smhs.2026.03.005
BibTeX
@article{Brooks2026,
author = {Brooks, George A},
title = {Molecular vehicles for therapeutic delivery of lactate in exercise and medicine},
journal = {Sports Medicine and Health Science},
year = {2026},
volume = {8},
number = {3},
pages = {240--246},
doi = {10.1016/j.smhs.2026.03.005}
}
EUVIMED